Oxbridge Clinical Inc. — Form D

Oxbridge Clinical Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-03. The offering totals $4.5M, of which $4.5M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-11-03
• Form: D
• Accession: 0002094607-25-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $4.5M
• Amount sold: $4.5M
• Investors: 3
• Date of first sale: 2025-10-08
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-562770

Issuer

• Name: Oxbridge Clinical Inc.
• CIK: 0002094607
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2023
• Address: 75 KNEELAND ST 14TH FL, BOSTON, MA, 02111
• Phone: 617-512-5730

Officers, directors & promoters (2)

More

• CIK 2094607 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search